Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Mu... by Havrdova, Eva, MD, Galetta, Steven, MD, Hutchinson, Michael, MD, Stefoski, Dusan, MD, Bates, David, MD, Polman, Chris H, MD, O'Connor, Paul W, MD, Giovannoni, Gavin, PhD, Phillips, J Theodore, MD, Lublin, Fred D, MD, Pace, Amy, ScD, Kim, Richard, MD, Hyde, Robert, PhD

Get full text

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT... by Kappos, Ludwig, MD, Freedman, Mark S, MD, Polman, Chris H, MD, Edan, Gilles, MD, Hartung, Hans-Peter, MD, Miller, David H, MD, Montalbán, Xavier, MD, Barkhof, Frederik, MD, Radü, Ernst-Wilhelm, MD, Metzig, Carola, MD, Bauer, Lars, MD, Lanius, Vivian, PhD, Sandbrink, Rupert, MD, Pohl, Christoph, MD

Get full text

Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis by Rudick, Richard A, MD, Polman, Chris H, MD

Get full text

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring by Kappos, Ludwig, Prof, Bates, David, MD, Hartung, Hans-Peter, MD, Havrdova, Eva, MD, Miller, David, MD, Polman, Chris H, MD, Ravnborg, Mads, MD, Hauser, Stephen L, MD, Rudick, Richard A, MD, Weiner, Howard L, MD, O'Connor, Paul W, MD, King, John, MD, Radue, Ernst Wilhelm, MD, Yousry, Tarek, MD, Major, Eugene O, PhD, Clifford, David B, MD

Get full text

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study by Kappos, Ludwig, Prof, Gold, Ralf, Prof, Miller, David H, Prof, MacManus, David G, MSc, Havrdova, Eva, MD, Limmroth, Volker, MD, Polman, Chris H, Prof, Schmierer, Klaus, PhD, Yousry, Tarek A, MD, Yang, Minhua, MS, Eraksoy, Mefkûre, Prof, Meluzinova, Eva, MD, Rektor, Ivan, MD, Dawson, Katherine T, MD, Sandrock, Alfred W, MD, O'Neill, Gilmore N, MB

Get full text

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT... by Kappos, Ludwig, Prof, Freedman, Mark S, Prof, Polman, Chris H, Prof, Edan, Gilles, Prof, Hartung, Hans-Peter, Prof, Miller, David H, Prof, Montalbán, Xavier, Prof, Barkhof, Frederik, Prof, Radü, Ernst-Wilhelm, Prof, Bauer, Lars, MD, Dahms, Susanne, PhD, Lanius, Vivian, PhD, Pohl, Christoph, MD, Sandbrink, Rupert, MD

Get full text

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis by Polman, Chris H, Prof, Bertolotto, Antonio, MD, Deisenhammer, Florian, Prof, Giovannoni, Gavin, Prof, Hartung, Hans-Peter, Prof, Hemmer, Bernhard, Prof, Killestein, Joep, MD, McFarland, Henry F, MD, Oger, Joel, Prof, Pachner, Andrew R, Prof, Petkau, John, Prof, Reder, Anthony T, MD, Reingold, Stephen C, PhD, Schellekens, Huub, Prof, Sørensen, Per Soelberg, Prof

Get full text

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 r... by Comi, Giancarlo, Prof, De Stefano, Nicola, Prof, Freedman, Mark S, Prof, Barkhof, Frederik, Prof, Polman, Chris H, Prof, Uitdehaag, Bernard MJ, Prof, Casset-Semanaz, Florence, MSc, Hennessy, Brian, MSc, Moraga, Margaretha Stam, MSc, Rocak, Sanda, PhD, Stubinski, Bettina, MD, Kappos, Ludwig, Prof

Get full text

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study by Swanton, Josephine K, MBBS, Rovira, Alex, MD, Tintore, Mar, PhD, Altmann, Daniel R, DPhil, Barkhof, Frederik, PhD, Filippi, Massimo, PhD, Huerga, Elena, Miszkiel, Katherine A, FRCP, Plant, Gordon T, FRCP, Polman, Chris, PhD, Rovaris, Marco, MD, Thompson, Alan J, FRCP, Montalban, Xavier, PhD, Miller, David H, FRCP

Get full text